Discovery and identification of serum potential biomarkers for pulmonary tuberculosis using iTRAQ-coupled two-dimensional LC-MS/MS

Proteomics

Volumn 14, Issue 2-3, 2014, Pages 322-331

  Xu, Dan Dan ^a   Deng, Dan Feng ^b   Li, Xiang ^c   Wei, Li Liang ^d   Li, Yan Yuan ^b   Yang, Xiu Yun ^e   Yu, Wei ^b   Wang, Chong ^a   Jiang, Ting Ting ^a   Li, Zhong Jie ^a   Chen, Zhong Liang ^a   Zhang, Xing ^a   Liu, Ji Yan ^a   Ping, Ze Peng ^a   Qiu, Yun Qing ^b   Li, Ji Cheng ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^d The Sixth Hospital of Shaoxing   (China)

^e TONGDE HOSPITAL OF ZHEJIANG PROVINCE   (China)

Author keywords

Biomedicine; ITRAQ coupled 2D LC MS MS; Potential biomarker; Pulmonary tuberculosis; Serum

Indexed keywords

APOLIPOPROTEIN C2; CD5 ANTIGEN LIKE; HYALURONAN BINDING PROTEIN 2; PROTEIN; RETINOL BINDING PROTEIN 4; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DOWN REGULATION; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOBLOTTING; ITRAQ COUPLED TWO DIMENSIONAL LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; METABOLISM; MIDDLE AGED; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STIMULUS RESPONSE; TANDEM MASS SPECTROMETRY; UPREGULATION; YOUNG ADULT;

BIOMEDICINE; ITRAQ-COUPLED 2D LC-MS/MS; POTENTIAL BIOMARKER; PULMONARY TUBERCULOSIS; SERUM;

ADULT; BIOLOGICAL MARKERS; BLOOD PROTEINS; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEOMICS; TANDEM MASS SPECTROMETRY; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84892839309     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201300383     Document Type: Article

References (50)

1. Walzl, G., Ronacher, K., Hanekom, W., Scriba, T. J., Zumla, A., Immunological biomarkers of tuberculosis. Nat. Rev. Immunol. 2011, 11, 343-354.
2. McNerney, R., Maeurer M., Abubakar I., Marais B. et al., Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities. J. Infect. Dis. 2012, 205, S147-S158.
3. World Health Orgnization. Global Tuberculosis Report 2012. WHO, Geneva, Switzerland 2012.
4. Fu, T., Xie, J., Progress on the biomarkers for tuberculosis diagnosis. Crit. Rev. Eukaryot. Gene Expr. 2011, 21, 379-391.
5. Lange, C., Mori, T., Advances in the diagnosis of tuberculosis. Respirology 2010, 15, 220-240.
6. Chegou, N. N., Hoek, K. G., Kriel, M., Warren, R. M. et al., Tuberculosis assays: past, present and future. Expert Rev. Anti. Infect. Ther. 2011, 9, 457-469.
7. Sester, M., Sotgiu, G., Lange, C., Giehl, C. et al., Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur. Respir. J. 2011, 37, 100-111.
8. Aabye, M. G., Ravn, P., PrayGod, G., Jeremiah, K. et al., The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis. PLoS One 2009, 4, e4220.
9. Ministry of Health of China. Diagnostic criteria for pulmonary tuberculosis. 2008. http://www.moh.gov.cn/publicfiles/business/cmsresources/zwgkzt/cmsrsdocument/doc3242.pdf.
10. Chen, G., Zhang, Y., Jin, X., Zhang, L. et al., Urinary proteomics analysis for renal injury in hypertensive disorders of pregnancy with iTRAQ labeling and LC-MS/MS. Proteomics Clin. Appl. 2011, 5, 300-310.
11. Wang, Y. S., Cao, R., Jin, H., Huang, Y. P. et al., Altered protein expression in serum from endometrial hyperplasia and carcinoma patients. J. Hematol. Oncol. 2011, 4, 15.
12. Jin, G. Z., Li, Y., Cong, W. M., Yu, H. et al., iTRAQ-2DLC-ESI-MS/MS based identification of a new set of immunohistochemical biomarkers for classification of dysplastic nodules and small hepatocellular carcinoma. J. Proteome Res. 2011, 10, 3418-3428.
13. Ray, S., Reddy, P. J., Jain, R., Gollapalli, K. et al., Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead. Proteomics 2011, 11, 2139-2161.
14. Cellulaire, B., Two-dimensional gel electrophoresis in proteomics: old, old fashioned, but it still climbs up the mountains. Proteomics 2002, 2, 3-10.
15. Maurya, P., Meleady, P., Dowling, P., Clynes, M., Proteomic approaches for serum biomarker discovery in cancer. Anticancer Res. 2007, 27, 1247-1255.
16. Poon, T. C., Opportunities and limitations of SELDI-TOF-MS in biomedical research: practical advices. Expert Rev. Proteomics 2007, 4, 51-65.
17. Zhou, H., Ranish, J. A., Watts, J. D., Aebersold, R., Quantitative proteome analysis by solid-phase isotope tagging and mass spectrometry. Nat. Biotechnol. 2002, 20, 512-515.
18. Mann, M., Functional and quantitative proteomics using SILAC. Nat. Rev. Mol. Cell Biol. 2006, 7, 952-958.
19. Abdi, F., Quinn, J. F., Jankovic, J., McIntosh, M. et al., Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. J. Alzheimers Dis. 2006, 9, 293-348.
20. Zhang, X., Yin, X., Yu, H., Liu, X. et al., Quantitative proteomic analysis of serum proteins in patients with Parkinson's disease using an isobaric tag for relative and absolute quantification labeling, two-dimensional liquid chromatography, and tandem mass spectrometry. Analyst 2012, 137, 490-495.
21. Hergenroeder, G., Redell, J. B., Moore, A. N., Dubinsky, W. P. et al., Identification of serum biomarkers in brain-injured adults: potential for predicting elevated intracranial pressure. J. Neurotrauma 2008, 25, 79-93.
22. Kolla, V., Jenö, P., Moes, S., Tercanli, S. et al., Quantitative proteomics analysis of maternal plasma in Down syndrome pregnancies using isobaric tagging reagent (iTRAQ). J. Biomed. Biotechnol. 2009, 2010, 1-10.
23. Zeng, G.-Q., Zhang, P.-F., Deng, X., Yu, F.-L. et al., Identification of candidate biomarkers for early detection of human lung squamous cell cancer by quantitative proteomics. Mol. Cell. Proteomics 2012, 11, M111.013946.
24. Deng, L., Su, T., Leng, A., Zhang, X. et al., Upregulation of soluble resistance-related calcium-binding protein (sorcin) in gastric cancer. Med. Oncol. 2010, 27, 1102-1108.
25. Bouchal, P., Roumeliotis, T., Hrstka, R., Nenutil, R. et al., Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis. J. Proteome Res. 2008, 8, 362-373.
26. Bowdish, D. M., Sakamoto, K., Kim, M.-J., Kroos, M. et al., MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis. PLoS Pathog. 2009, 5, e1000474.
27. Rosas-Taraco, A. G., Revol, A., Salinas-Carmona, M. C., Rendon, A. et al., CD14 C (-159) T polymorphism is a risk factor for development of pulmonary tuberculosis. J. Infect. Dis. 2007, 196, 1698-1706.
28. Lawn, S. D., Labeta, M., Arias, M., Acheampong, J., Griffin, G., Elevated serum concentrations of soluble CD14 in HIV- and HIV+ patients with tuberculosis in Africa: prolonged elevation during anti-tuberculosis treatment. Clin. Exp. Immunol. 2000, 120, 483-487.
29. Zhao, M., Xue, Y., Zhao, Z., Li, F. et al., Association of CD14 G (-1145) A and C (-159) T polymorphisms with reduced risk for tuberculosis in a Chinese Han population. Genet. Mol. Res. 2012, 11, 3425-3431.
30. Pasula, R., Wisniowski, P., Martin II, W. J., Fibronectin facilitates Mycobacterium tuberculosis attachment to murine alveolar macrophages. Infect. Immun. 2002, 70, 1287-1292.
31. Rojas, R. E., Thomas, J. J., Gehring, A. J., Hill, P. J. et al., Phosphatidylinositol mannoside from Mycobacterium tuberculosis binds α5β1 integrin (VLA-5) on CD4+ T cells and induces adhesion to fibronectin. J. Immunol. 2006, 177, 2959-2968.
32. Shamir, R., Hartman, C., Karry, R., Pavlotzky, E. et al., Paraoxonases (PONs) 1, 2, and 3 are expressed in human and mouse gastrointestinal tract and in Caco-2 cell line: selective secretion of PON1 and PON2. Free Radic. Biol. Med. 2005, 39, 336-344.
33. Fuhrman, B., Volkova, N., Aviram, M., Paraoxonase 1 (PON1) is present in postprandial chylomicrons. Atherosclerosis 2005, 180, 55-61.
34. Deakin, S., Moren, X., James, R. W., Very low density lipoproteins provide a vector for secretion of paraoxonase-1 from cells. Atherosclerosis 2005, 179, 17-25.
35. Aviram, M., Hardak, E., Vaya, J., Mahmood, S. et al., Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities. Circulation 2000, 101, 2510-2517.
36. Durrington, P., Mackness, B., Mackness, M., Paraoxonase and atherosclerosis. Arterioscler. Thromb. Vas. Biol. 2001, 21, 473-480.
37. Selek, S., Cosar, N., Kocyigit, A., Erel, O. et al., PON1 activity and total oxidant status in patients with active pulmonary tuberculosis. Clin. Biochem. 2008, 41, 140-144.
38. Naderi, M., Hashemi, M., Komijani-Bozchaloei, F., Moazeni-Roodi, A., Momenimoghaddam, M., Serum paraoxonase and arylesterase activities in patients with pulmonary tuberculosis. Pathophysiology 2011, 18, 117-120.
39. Song, Z., Dong, R., Fan, Y., Zheng, S., Identification of serum protein biomarkers in biliary atresia by mass spectrometry and enzyme-linked immunosorbent assay. J. Pediatr. Gastroenterol. Nutr. 2012, 55, 370-375.
40. Pérez-Guzmán, C., Vargas, M. H., Hypocholesterolemia: a major risk factor for developing pulmonary tuberculosis? Med. Hypotheses 2006, 66, 1227-1230.
41. Deniz, O., Gumus, S., Yaman, H., Ciftci, F. et al., Serum total cholesterol, HDL-C and LDL-C concentrations significantly correlate with the radiological extent of disease and the degree of smear positivity in patients with pulmonary tuberculosis. Clin. Biochem. 2007, 40, 162-166.
42. Sarrias, M.-R., Roselló, S., Sánchez-Barbero, F., Sierra, J. M. et al., A role for human Sp as a pattern recognition receptor. J. Biol. Chem. 2005, 280, 35391-35398.
43. Józefowski, S., Sobota, A., Hamasur, B., Pawlowski, A., Kwiatkowska, K., Mycobacterium tuberculosis lipoarabinomannan enhances LPS-induced TNF-α production and inhibits NO secretion by engaging scavenger receptors. Microb. Pathog. 2011, 50, 350-359.
44. Etscheid, M., Kreß, J., Seitz, R., Dodt, J., The hyaluronic acid-binding protease: a novel vascular and inflammatory mediator? Int. Immunopharmacol. 2008, 8, 166-170.
45. Patrick, A., Acute lung injury regulation by hyaluronan. J. Allergy Ther. 2011, S4, 003.
46. Lennon, F. E., Singleton, P. A., Role of hyaluronan and hyaluronan-binding proteins in lung pathobiology. Am. J. Physiol. Lung Cell Mol. Physiol. 2011, 301, L137-L147.
47. Mambetsariev, N., Mirzapoiazova, T., Mambetsariev, B., Sammani, S. et al., Hyaluronic acid binding protein 2 is a novel regulator of vascular integrity. Arterioscler. Thromb. Vas. Biol. 2010, 30, 483-490.
48. Wygrecka, M., Markart, P., Fink, L., Guenther, A., Preissner, K. T., Raised protein levels and altered cellular expression of factor VII activating protease (FSAP) in the lungs of patients with acute respiratory distress syndrome (ARDS). Thorax 2007, 62, 880-888.
49. Crowle, A. J., Ross, E. J., Inhibition by retinoic acid of multiplication of virulent tubercle bacilli in cultured human macrophages. Infect. Immun. 1989, 57, 840-844.
50. Tanaka, T., Sakurada, S., Kano, K., Takahashi, E. et al., Identification of tuberculosis-associated proteins in whole blood supernatant. BMC Infect. Dis. 2011, 11, 71.